Abstract:Abstract Fosfomycin is a bactericidal antibiotic, analogous to phosphoenolpyruvate (PEP) that exerts its activity by inhibiting the activity of MurA. This enzyme catalyzes the first step of peptidoglycan biosynthesis, the transfer of enolpyruvate from PEP to uridine-diphosphate-N-acetylglucosamine. Fosfomycin is increasingly used in the last years, mainly for treating infections caused by Gram-negative multidrug resistant bacteria as Stenotrophomonas maltophilia , an opportunistic pathogen characterized by its low susceptibility to antibiotics of common use. The mechanisms of mutational resistance to fosfomycin in S. maltophilia were studied in the current work. None of the mechanisms so far described for other organisms, which include the production of fosfomycin inactivating enzymes, target modification, induction of alternative peptidoglycan biosynthesis pathway and the impaired entrance of the antibiotic, are involved in the acquisition of such resistance by this bacterial species. Rather the unique cause of resistance in the studied mutants is the mutational inactivation of different enzymes belonging to the Embden-Meyerhof-Parnas central metabolism pathway. The amount of intracellular fosfomycin accumulation did not change in any of these mutants showing that neither the inactivation nor the transport of the antibiotic were involved. Transcriptomic analysis also showed that the mutants did not present changes in the expression level of putative alternative peptidoglycan biosynthesis pathway genes neither any related enzyme. Finally, the mutants did not present an increased PEP concentration that might compete with fosfomycin for its binding to MurA. Based on these results, we describe a completely novel mechanism of antibiotic resistance based on the remodeling of S. maltophilia metabolism. Significance Antibiotic resistance (AR) has been largely considered as a specific bacterial response to an antibiotic challenge. Indeed, its study has been mainly concentrated in mechanisms that affect the antibiotics (mutations in transporters, the activity of efflux pumps and antibiotic modifying enzymes) or their targets (i.e.: target mutations, protection or bypass). Usually, AR-associated metabolic changes were considered to be a consequence (fitness costs) and not a cause of AR. Herein, we show that strong alterations in the bacterial metabolism can also be the cause of AR. In the study here presented, Stenotrophomonas maltophilia acquires fosfomycin resistance through the inactivation of glycolytic enzymes belonging to the Embden-Meyerhof-Parnas. Besides resistance to fosfomycin, this inactivation also impairs the bacterial gluconeogenic pathway. Together with previous work showing that AR can be under metabolic control, our results provide evidence that AR is intertwined with the bacterial metabolism.

Asp50Glu Mutation in MurA Results in Fosfomycin Resistance in Enterococcus Faecium

Prevalence of Fosfomycin Resistance in Methicillin-Resistant Staphylococcus Aureus Isolated from Patients in a University Hospital in China from 2013 to 2015.

Prevalence and mechanisms of fosfomycin resistance among KPC-producing <i>Klebsiella pneumoniae</i> clinical isolates in China

The novel fosfomycin resistance gene fosY is present on a genomic island in CC1 methicillin-resistant <i>Staphylococcus aureus</i>

Fosfomycin Resistance among Vancomycin-Resistant Enterococci Owing to Transfer of a Plasmid Harbouring the Fosb Gene.

Plasmid Mediated Fosfomycin Resistance and Its Mechanism in Extended-Spectrum Β-Lactamases Producing Klebsiella Pneumonia

Identification of a Novel Fosfomycin-Resistant UDP-N-acetylglucosamine Enolpyruvyl Transferase (mura) from a Soil Metagenome.

Prevalence of 16S Rrna Methylase Conferring High-Level Aminoglycoside Resistance in Escherichia Coli in China

Mutation in Cyp51a and High Expression of Efflux Pump Gene of Aspergillus Fumigatus Induced by Propiconazole in Liquid Medium and Soil.

Mutations of the Transporter Proteins GlpT and UhpT Confer Fosfomycin Resistance in Staphylococcus Aureus.

Prevalence of Fosfomycin Resistance and Mutations in Mura, Glpt, and Uhpt in Methicillin-Resistant Staphylococcus Aureus Strains Isolated from Blood and Cerebrospinal Fluid Samples.

Lyme disease enolpyruvyl-UDP-GlcNAc synthase: fosfomycin-resistant MurA from Borrelia burgdorferi, a fosfomycin-sensitive mutant, and the catalytic role of the active site Asp

High-Level Fosfomycin Resistance in Vancomycin-Resistant Enterococcus Faecium

Antimicrobial Susceptibility And Molecular Mechanisms Of Fosfomycin Resistance In Clinical Escherichia Coli Isolates In Mainland China

Mechanisms of fosfomycin resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae

Hpta Mutation May Mediate Fosfomycin Resistance in Methicillin-Resistant Staphylococcus Aureus Clinical Isolates.

The inactivation of enzymes belonging to the central carbon metabolism, a novel mechanism of developing antibiotic resistance

The Fosfomycin Resistance Gene Fosb3 is Located on a Transferable, Extrachromosomal Circular Intermediate in Clinical Enterococcus Faecium Isolates.

High Prevalence and Overexpression of Fosfomycin-Resistant Gene Fosx in Enterococcus Faecium from China

Identification of fosA10, a Novel Plasmid-Mediated Fosfomycin Resistance Gene of Klebsiella pneumoniae Origin, in Escherichia coli

Widespread Fosfomycin Resistance in Gram-Negative Bacteria Attributable to the Chromosomal fosA Gene